William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 20,000 shares at $59.07 ($1.2M) on 2025-03-04, disclosed to the SEC on 2025-03-04.
Scheduled sale ($1.2M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |